Fintel reports that on October 27, 2025, HC Wainwright & Co. maintained coverage of Kyverna Therapeutics (NasdaqGS:KYTX) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback